The retinoblastoma gene product regulates Sp1-mediated transcription

We have demonstrated that the retinoblastoma gene product (Rb) can positively regulate transcription from the fourth promoter of the insulinlike growth factor II gene. Two copies of a motif (the retinoblastoma control element) similar to that found in the human c-fos, transforming growth factor beta 1, and c-myc promoters are responsible for conferring Rb regulation to the fourth promoter of the insulinlike growth factor II gene. We have shown that the transcription factor Sp1 can bind to and stimulate transcription from the retinoblastoma control element motif. Moreover, by using a GAL4-Sp1 fusion protein, we have directly demonstrated that Rb positively regulates Sp1 transcriptional activity in vivo. These results indicate that Rb can function as a positive regulator of transcription and that Sp1 is one potential target, either directly or indirectly, for transcriptional regulation by Rb.

[1]  T. Shenk,et al.  Transcriptional Activation by the Adenovirus E1A Proteins , 1993 .

[2]  A. Rustgi,et al.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product , 1991, Nature.

[3]  T. Hunt,et al.  Cyclin A and the retinoblastoma gene product complex with a common transcription factor , 1991, Nature.

[4]  Pearl S Huang,et al.  Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product , 1991, Nature.

[5]  R. Weinmann,et al.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F , 1991, Cell.

[6]  Joseph R. Nevins,et al.  The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.

[7]  J. M,et al.  How the Retinoblastoma Gene May Onhibit Cell Growth , 1991, Science.

[8]  R. Tjian,et al.  Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription , 1991, Cell.

[9]  M. Sporn,et al.  Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Y. Lee,et al.  A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product , 1991, Nature.

[11]  F. Kaye,et al.  Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product , 1991, Cell.

[12]  M. Green,et al.  Retinoblastoma. A transcriptional tryst. , 1991, Nature.

[13]  P. Robbins,et al.  Negative regulation of human c-fos expression by the retinoblastoma gene product , 1991, Nature.

[14]  J. Sussenbach,et al.  Identification and initial characterization of a fourth leader exon and promoter of the human IGF-II gene. , 1990, Biochimica et biophysica acta.

[15]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[16]  P. Yaciuk,et al.  TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains , 1990, Cell.

[17]  R. Weinberg,et al.  Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Lee,et al.  Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. , 1990, Science.

[19]  London P. Cuatrecasas.  Peptide Growth Factors and Their Receptors I , 1990, Handbook of Experimental Pharmacology.

[20]  S. Friend,et al.  Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Weinberg,et al.  Point mutational inactivation of the retinoblastoma antioncogene. , 1989, Science.

[22]  R. Tjian,et al.  Distinct regions of Sp1 modulate DNA binding and transcriptional activation. , 1988, Science.

[23]  J. Varley,et al.  Structural rearrangement of the retinoblastoma gene in human breast carcinoma. , 1988, Science.

[24]  R. A. van der Kammen,et al.  Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. , 1988, Biochimica et biophysica acta.

[25]  Mark Ptashne,et al.  Negative effect of the transcriptional activator GAL4 , 1988, Nature.

[26]  J. Minna,et al.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.

[27]  K. Ishizaki,et al.  Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. , 1988, Cancer research.

[28]  W. Lee,et al.  Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.

[29]  R. Weichselbaum,et al.  Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Yokota,et al.  Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. , 1988, Oncogene.

[31]  R. Weinberg,et al.  Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Hinrichs,et al.  Structural evidence for the authenticity of the human retinoblastoma gene. , 1987, Science.

[33]  W. Lee,et al.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.

[34]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.